- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07586527
Adapted Mindfulness Training for Diabetic Patients With Impaired Hypoglycemia Awareness
8 mai 2026 mis à jour par: Mengyao Han, Yangzhou University
Impact of Adapted Mindfulness Training Integrating Interoception on Diabetic Patients With Impaired Awareness of Hypoglycemia: A Randomized Controlled Trial
The purpose of this randomized controlled trial is to evaluate the effectiveness of an 8-week interoception-integrated adapted mindfulness training program for patients with type 1 or type 2 diabetes who experience impaired awareness of hypoglycemia (IAH).
The study aims to determine whether this mindfulness intervention, which includes techniques such as body scanning and mindful eating, can help patients better recognize early physiological signals of low blood sugar compared to routine care.
Researchers will measure changes in participants' interoceptive awareness and the severity of their IAH over a 3-month follow-up period.
The ultimate goal is to provide a practical psychological approach to improve symptom perception and reduce the risk of severe hypoglycemic events in diabetic patients.
Aperçu de l'étude
Statut
Pas encore de recrutement
Les conditions
Intervention / Traitement
Description détaillée
Diabetic patients are prone to hypoglycemia during insulin therapy, and repeated episodes can lead to impaired awareness of hypoglycemia (IAH), significantly increasing the incidence of severe hypoglycemia and adverse health outcomes.
Recent studies indicate that altered interoceptive awareness is closely associated with an increased risk of IAH, and mindfulness interventions can effectively enhance an individual's interoceptive awareness.
This study aims to explore the effects of an interoception-integrated adapted mindfulness training program on interoceptive awareness and impaired awareness of hypoglycemia in diabetic patients.
This study is a two-arm, parallel-group randomized controlled trial.
It plans to recruit 100 type 1 or type 2 diabetic patients with IAH who meet the eligibility criteria (e.g., Gold score ≥ 4 and Clarke score ≥ 4) from two community health centers in Yangzhou.
Participants will be randomly assigned in a 1:1 ratio to either the intervention group (n=50) or the control group (n=50).
The control group will receive routine treatment, examinations, nursing care, and health education.
On this basis, the intervention group will receive an 8-week interoception-integrated adapted mindfulness training program, conducted once a week (1-1.5 hours per session).
Based on Mindfulness-Based Stress Reduction (MBSR), the program utilizes core techniques such as body scanning, mindful eating, and mindful walking to reinforce patients' perception and awareness of early physiological signals of hypoglycemia, supplemented by daily home practices.
Primary outcomes are the patients' interoceptive awareness (assessed by the MAIA-2 scale) and the severity of impaired awareness of hypoglycemia (evaluated by the Clarke and Gold questionnaires).
Secondary outcomes include mindfulness levels (FFMQ) and negative cognitive processing bias (NCPBQ).
Data collection time points are set at pre-intervention (T0), immediately post-intervention (T1), 1 month post-intervention (T2), and 3 months post-intervention (T3).
Statistical analyses will employ descriptive statistics, univariate analysis, and Generalized Estimating Equations (GEE) to evaluate the intervention effects.
This study is expected to provide a practical psychological intervention to improve symptom perception in diabetic patients with IAH, thereby reducing the incidence of severe hypoglycemia and improving clinical outcomes.
Type d'étude
Interventionnel
Inscription (Estimé)
100
Phase
- N'est pas applicable
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- Diagnosed with type 1 or type 2 diabetes mellitus according to the latest American Diabetes Association (ADA) Standards of Care in Diabetes;
- Receiving insulin therapy for ≥ 1 year;
- Age between 18 and 80 years (inclusive);
- Duration of diabetes ≥ 5 years;
- Gold score ≥ 4 and Clarke score ≥ 4;
- Voluntary participation and provision of signed informed consent.
Exclusion Criteria:
- Prior experience with mindfulness interventions;
- Diagnosed with cognitive impairment, psychiatric disorders, or other severe physical comorbidities;
- Current use of psychotropic medications;
- Pregnant or lactating women, or women of childbearing potential not using effective contraception.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Intervention Group
Participants receive an 8-week interoception-integrated adapted mindfulness training program, in addition to routine treatment, examinations, nursing care, and health education.
|
An 8-week adapted mindfulness program, based on Mindfulness-Based Stress Reduction (MBSR), is delivered to patients with Impaired Awareness of Hypoglycemia (IAH) by a multidisciplinary team.
It involves weekly 1-1.5 hour face-to-face group sessions (8-10 participants) and daily home practices supervised via a WeChat group.
Tailored to IAH, the curriculum integrates core skills (mindful meditation, yoga, breathing, and walking) with IAH-specific elements.
By training self-awareness, attentional control, and emotional regulation, it aims to enhance interoceptive awareness.
This strengthens hypoglycemia-related perceptual behaviors, helping patients acquire self-regulation skills, attend to physical sensations of hypoglycemia, perceive nocturnal hypoglycemia, and identify fear of hypoglycemia.
|
|
Comparateur actif: Control Group
Participants receive routine treatment, examinations, nursing care, and health education only, without the mindfulness training during the 8-week study period.
|
The control group receives routine medical care, examinations, nursing, and health education.
While they undergo the same follow-up schedule as the intervention group, no mindfulness practice guidance is provided during the study period.
Upon the conclusion of the study, mindfulness-related materials will be distributed to these participants.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Clark Score
Délai: Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
|
Gold Score
Délai: Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
|
Multidimensional Assessment of Interoceptive Awareness Version 2
Délai: Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Five Facet Mindfulness
Délai: Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
|
Negative Cognitive Processing Bias Questionnaire
Délai: Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Estimé)
1 juin 2026
Achèvement primaire (Estimé)
1 juin 2027
Achèvement de l'étude (Estimé)
1 juin 2027
Dates d'inscription aux études
Première soumission
8 mai 2026
Première soumission répondant aux critères de contrôle qualité
8 mai 2026
Première publication (Réel)
14 mai 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
14 mai 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
8 mai 2026
Dernière vérification
1 mai 2026
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- YZUHL20250040
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .